EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Discordant marrow MRD and PET ‐ CT in myeloma: A four‐state language for joint reporting

Max Mendez-Lopez iD, Marco Talarico iD, Elena Zamagni iD, Thomas Lehmann iD

British Journal of Haematology · 03.11.2026

DOI: 10.1111/bjh.70933 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 03.11.2026. Verfasst von Max Mendez-Lopez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology/Hematology and Laboratory for Experimental Hematology, HOCH Health Ostschweiz, St Gallen, Switzerland. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a Nutshell, discordant bone marrow measurable residual disease (BM‐MRD) and positron emission tomography‐computed tomography (PET‐CT) assessments in multiple myeloma do not simply represent assay disagreement. They can provide clinically relevant information because the direction of discordance changes the interpretation of response: BM‐MRD‐negative/PET‐positive disease indicates PET‐visible disease outside the sampled marrow compartment, whereas BM‐MRD‐positive/PET‐negative disease reflects marrow persistence without PET‐visible disease. This distinction matters for defining deep response, interpreting MRD‐driven end‐points and designing studies of response‐adapted treatment. A four‐state language turns discordance from an ambiguous finding into a reportable response framework.

Schlagwörter

Stichwörter der Autor:innen

PET‐CTdiscordancemeasurable residual diseasemultiple myelomaresponse assessment

Autor:innen und Institutionen

  • Department of Medical Oncology/Hematology and Laboratory for Experimental Hematology, HOCH Health Ostschweiz, St Gallen, Switzerland.
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
  • Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.

ORCID-Profile: Max Mendez-Lopez, Marco Talarico, Elena Zamagni, Thomas Lehmann

Zitieren

APA

Mendez-Lopez, M., Talarico, M., Zamagni, E., & Lehmann, T. (2026). Discordant marrow MRD and PET ‐ CT in myeloma: A four‐state language for joint reporting. British Journal of Haematology. https://doi.org/10.1111/bjh.70933

Vancouver

Mendez-Lopez M, Talarico M, Zamagni E, Lehmann T. Discordant marrow MRD and PET ‐ CT in myeloma: A four‐state language for joint reporting. British Journal of Haematology. 2026. doi:10.1111/bjh.70933

BibTeX
@article{MendezLopez2026,
  author = {Mendez-Lopez, Max and Talarico, Marco and Zamagni, Elena and Lehmann, Thomas},
  title = {Discordant marrow MRD and PET ‐ CT in myeloma: A four‐state language for joint reporting},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70933}
}
Kostenlos starten →